Huhtamaki India (509820) Q4 2019 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2019 earnings summary
27 Oct, 2026Executive summary
FY2019 revenue from operations rose 9% YoY to ₹25,823.7 million; EBIT increased 45.8% to ₹2,227.1 million and PAT reached ₹1,700.4 million.
Stronger product mix, operating performance and lower interest costs supported earnings; a prior-year tax and interest provision was also written back after a favorable court order.
Financial highlights
Sales were ₹2,547.67 crore versus ₹2,332.11 crore in 2018; EBITDA rose to ₹309.64 crore from ₹238.09 crore.
PBT before exceptional items increased 77.5% to ₹201.58 crore; PAT rose to ₹170.04 crore from ₹34.88 crore.
Revenue from operations, including other operating revenue, was ₹2,582.37 crore; reported EPS was ₹22.52 versus ₹4.62.
Adjusted for the favorable write-back of ₹21.07 crore income tax and ₹10.00 crore related interest, earnings growth also reflected higher sales, improved mix and operations.
Outlook and guidance
Strategic priorities centered on growth, competitiveness, talent and sustainability, with investment in production infrastructure, digitalisation and HR processes.
COVID-19 was expected to affect future operations; the scale of impact depended on the pandemic’s development and its effects on business.
The board revised its FY2019 final dividend recommendation from ₹5 to ₹3 per share in May 2020 to conserve resources amid the COVID-19 slowdown.
Latest events from Huhtamaki India
- Q3 net sales rose 23.7%, while a Rs. 96 million restructuring charge cut PAT 19.1%.509820
Q3 2026 - COVID disruption cut earnings, while exports and sustainability investments supported the path forward.509820
Q4 2020 - Sales grew, but inflation, VRS costs and working capital drove a loss and higher debt.509820
Q4 2021 - Land-sale gains lifted PAT as operating margins improved despite lower revenue.509820
Q4 2023 - Sales grew, but costs and depreciation pressured earnings as new capacity came onstream.509820
Q4 2007 - Core sales grew 33%, while price pressure and higher interest weighed on FY97.509820
Q4 96/97 - Sales and volume advanced, but higher costs and price pressure cut FY 1997-98 profit.509820
Q4 97/98 - Profit rebounded as expansion and Van Leer funding met persistent pricing and input-cost pressure.509820
Q4 98/99 - Sales grew 12.2% in 2000, but input inflation and weak H2 demand squeezed margins.509820
Q4 2000